BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biobanks Market: Increasing Prevalence of Chronic Diseases to Drive the Market

  The global biobanks market is expected to witness strong growth during the forecast period between 2021 and 2031.

  September 7, 2022

   · 

  6 min read
• Business

  Acupath Laboratories Inc. and UroGPO Announce a Partnership to Offer the URO17® Bladder Cancer Biomarker in the United States

  Acupath Labs and UroGPO announced in April a partnership to make URO17® available to the UroGPO membership nationwide.

  September 7, 2022

   · 

  3 min read
• Infectious Disease Diagnostics Market: Rise in Funding for Research on the Diagnosis of Infectious Diseases is Projected to Drive the Market

  Infectious diseases are caused by microorganisms such as bacteria and viruses.

  September 7, 2022

   · 

  5 min read
• Western Blotting Processors Market Competitive Landscape Analysis with Forecast by 2026

  The Western Blotting Processors are majorly inconsistence on the basis of efficiency of detecting protein traces in samples.

  September 7, 2022

   · 

  5 min read
• Renal Denervation Technologies Market is expected to witness a prolific CAGR over the 2022-2026 forecast period.

  Demand for renal denervation procedures is anticipated to be aided by various authorities and government organizations increasing funding for R&D initiatives for renovascular hypertension treatment.

  September 7, 2022

   · 

  6 min read
• Genetown

  Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

  Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the company will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference.

  September 7, 2022

   · 

  1 min read